Pharmaceutical giant Johnson & Johnson is partnering with the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services to fund over $1 billion in COVID-19 vaccine and antiviral treatment research and development, the company said on Monday. The partnership is an expansion of an existing agreement between BARDA and J&J's Janssen Pharmaceutical Companies division. With the agreement, the company is setting a goal of providing a global supply of more than one billion doses of the vaccine, which J&J expects to have in clinical trials by September 2020 at the latest. from Yahoo Tech https://ift.tt/2JDqGEd
Is it feast or famine for food delivery startups during the coronavirus pandemic? The UK's Deliveroo has confirmed it's axing more than 350 staff -- or around 15% of its global headcount. A Deliveroo spokesman blamed the cuts on the coronavirus crisis, saying the public health emergency has put pressure on the business to reduce long-term costs. from Yahoo Tech https://ift.tt/3cT72QQ
Despite traffic for many online properties being at an all-time high, advertising has fallen off a cliff because of the downturn in consumer activity outside the home and the wider economic pressures resulting from the COVID-19 pandemic. The ad-based social networking and media company said that in Q1 it made $808 million in revenues, actually up 3% on a year ago, with monetizable daily active users (Twitter's own metric for measuring its audience) grew 24% to 166 million, an all-time high, adding 14 million average mDAUs since Q4 (152 million) and 32 million since Q1 of last year (134 million). Analysts had expected, on average, to see $775.96 million in revenues on earnings per share of $0.10, so Twitter beat on sales, and missed on earnings. from Yahoo Tech https://ift.tt/2zEqi6o
Comments
Post a Comment